61314-326Level 3
ZARXIO (filgrastim-sndz)
**Product type:** Human Prescription Drug
**Active ingredient:** FILGRASTIM
**Strength:** 480 ug/.8mL
**Dosage form:** Injection, Solution
**Route:** Intravenous; Subcutaneous
**Labeler:** Sandoz Inc.
**Marketing category:** BLA (BLA125553)
**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/61314-326Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.